CompuMed Statistics
Total Valuation
CompuMed has a market cap or net worth of 3.98 million.
| Market Cap | 3.98M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CompuMed has 1.33 million shares outstanding.
| Current Share Class | 1.33M |
| Shares Outstanding | 1.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.35 |
| PB Ratio | 31.32 |
| P/TBV Ratio | 441.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1,325.72 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.05 |
| Quick Ratio | 0.97 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | -11.64 |
| Interest Coverage | -5.95 |
Financial Efficiency
Return on equity (ROE) is -30.37% and return on invested capital (ROIC) is -29.45%.
| Return on Equity (ROE) | -30.37% |
| Return on Assets (ROA) | -13.01% |
| Return on Invested Capital (ROIC) | -29.45% |
| Return on Capital Employed (ROCE) | -53.91% |
| Revenue Per Employee | 188,222 |
| Profits Per Employee | -16,222 |
| Employee Count | 9 |
| Asset Turnover | 2.69 |
| Inventory Turnover | 45.57 |
Taxes
| Income Tax | -7,351 |
| Effective Tax Rate | -14.14% |
Stock Price Statistics
The stock price has increased by +57.90% in the last 52 weeks. The beta is -0.02, so CompuMed's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +57.90% |
| 50-Day Moving Average | 3.37 |
| 200-Day Moving Average | 3.44 |
| Relative Strength Index (RSI) | 42.74 |
| Average Volume (20 Days) | 732 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | 5,387 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.58 |
Income Statement
In the last 12 months, CompuMed had revenue of 1.69 million and -146,000 in losses. Loss per share was -0.13.
| Revenue | 1.69M |
| Gross Profit | 851,000 |
| Operating Income | -131,000 |
| Pretax Income | -41,000 |
| Net Income | -146,000 |
| EBITDA | -45,000 |
| EBIT | -131,000 |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 4,000 in cash and 163,000 in debt, giving a net cash position of -159,000 or -0.12 per share.
| Cash & Cash Equivalents | 4,000 |
| Total Debt | 163,000 |
| Net Cash | -159,000 |
| Net Cash Per Share | -0.12 |
| Equity (Book Value) | 127,000 |
| Book Value Per Share | 0.11 |
| Working Capital | 19,000 |
Cash Flow
In the last 12 months, operating cash flow was 3,000 and capital expenditures -17,000, giving a free cash flow of -14,000.
| Operating Cash Flow | 3,000 |
| Capital Expenditures | -17,000 |
| Free Cash Flow | -14,000 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 50.24%, with operating and profit margins of -7.73% and -2.42%.
| Gross Margin | 50.24% |
| Operating Margin | -7.73% |
| Pretax Margin | -2.42% |
| Profit Margin | -2.42% |
| EBITDA Margin | -2.66% |
| EBIT Margin | -7.73% |
| FCF Margin | n/a |
Dividends & Yields
CompuMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.66% |
| Shareholder Yield | -1.66% |
| Earnings Yield | -3.67% |
| FCF Yield | -0.35% |
Stock Splits
The last stock split was on May 23, 2022. It was a reverse split with a ratio of 0.04.
| Last Split Date | May 23, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
CompuMed has an Altman Z-Score of -82.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -82.64 |
| Piotroski F-Score | 6 |